115223
  • Log in
The Daily Sceptic
No Result
View All Result
  • Articles
  • About
  • Archive
    • ARCHIVE
    • NEWS ROUND-UPS
  • Forum
  • Donate
  • Newsletter
The Daily Sceptic
No Result
View All Result

mRNA Vaccines Significantly Associated With Deadly Blood Clots, Major Study Finds

by Will Jones
20 May 2022 7:00 AM

Blood-clotting condition cerebral venous thrombosis (CVT), which can cause serious neurological damage, is significantly associated with mRNA Covid vaccination, a major study in leading medical journal Vaccines has found.

The research team analysed 1,154,023 adverse event reports from more than 130 countries logged with VigiBase, the World Health Organisation’s global deduplicated database, and found a “potential safety signal for CVT occurrence after COVID-19 mRNA vaccination”.

The authors note many reports were in younger people and the conditions were serious: “CVTs were commonly reported in patients aged 18-44 and 45-64 years, more frequently in women, and mainly in Europe and America… More than 90% of the patients were in serious condition, and 33% did not recover or died.”

The researchers take into account under-reporting to produce estimates of increased risk above a baseline: around 3.5 times greater risk for mRNA vaccines and seven times greater risk for AstraZeneca. This means the CVT risk from mRNA vaccines, while high, is around half that of AstraZeneca.

They also found that CVT following mRNA vaccination is only around a third as deadly as that following AstraZeneca vaccination. This means mRNA vaccines lead to deadly CVT around a sixth as often as AstraZeneca, which may explain why the condition is particularly associated with the AstraZeneca jab.

The researchers cite earlier studies to suggest the mechanism relates to the spike protein binding to the wall of blood vessels, particularly in the brain, and activating clotting mechanisms.

There are few reports on CVT after mRNA-based COVID-19 vaccination. These studies suggested that CVT occurrences related to mRNA-based COVID-19 vaccines may be due to endothelial dysfunction caused by spike glycoprotein interactions with endothelial cells resulting in immunothrombosis. If the spike glycoprotein of mRNA-based COVID-19 vaccines binds to the angiotensin-converting enzyme 2 receptor, several inflammatory and thrombogenic molecules, such as leukocyte chemotactic factors, cell adhesion molecules (vascular cell adhesion molecule 1 and intercellular adhesion molecule 1), and procoagulant cytokines, can be activated. This mechanism may cause endothelial dysfunction, particularly in brain endothelial cells, which could contribute to a significant disruption of brain endothelial barrier integrity, ultimately promoting thrombus formation. Moreover, a previous study suggested that the spike glycoprotein may induce platelet aggregation and activation and eventually result in thrombus formation. Although the period of time in which the spike glycoprotein persists has not been clearly established, several studies have suggested that it may last for weeks. Thus, spike glycoprotein-related platelet activation triggered by mRNA-based COVID-19 vaccines could explain the trend of CVT occurrences after mRNA-based COVID-19 vaccinations. Furthermore, in line with these previous case reports, our results showed that CVT occurred mainly within a few weeks of mRNA-based COVID-19 vaccinations.

Here is the study abstract, summarising the findings.

Cerebral venous thrombosis (CVT), a rare thrombotic event that can cause serious neurologic deficits, has been reported after some ChAdOx1 [AstraZeneca] nCoV-19 vaccinations against coronavirus disease 2019 (COVID-19). However, there are few reports of associations between COVID-19 mRNA vaccination and CVT. We retrospectively analysed CVT occurrence, time of onset after vaccination, outcomes (recovered/not recovered), and death after COVID-19 vaccination from adverse drug reactions (ADR) reports in VigiBase. A disproportionality analysis was performed regarding COVID-19 mRNA vaccines (BNT162b2 [Pfizer] and mRNA-1273 [Moderna]) and the ChAdOx1 nCoV-19 vaccine. We identified 756 (0.07%) CVT cases (620 (0.05%) after BNT162b2 and 136 (0.01%) after mRNA-1273) of 1,154,023 mRNA vaccine-related ADRs. Significant positive safety signals were noted for COVID-19 mRNA vaccines (95% lower end of information component = 1.56; reporting odds ratio with 95% confidence interval (CI) = 3.27). The median days to CVT onset differed significantly between the BNT162b2 and ChAdOx1 nCoV-19 vaccines (12 (interquartile range, 3-22) and 11 (interquartile range, 7-16), respectively; p = 0.02). Fewer CVT patients died after receiving mRNA vaccines than after receiving the ChAdOx1 nCoV-19 vaccine (odds ratio, 0.32; 95% CI, 0.22–0.45; p < 0.001). We noted a potential safety signal for CVT occurrence after COVID-19 mRNA vaccination. Therefore, awareness about the risk of CVT, even after COVID-19 mRNA vaccination, is necessary.

The association of blood-clotting adverse reactions with adenovirus vector vaccines like AstraZeneca and Johnson and Johnson have led to them being restricted or withdrawn in many countries, most recently by the U.S. FDA. The fact that this adverse reaction is also associated with mRNA vaccines, albeit in a somewhat less deadly form, suggests that the differential treatment of the two vaccine types on this basis is unlikely to be tenable.

Tags: Adverse eventsAstraZenecaBlood clotsCVTModernamRNA vaccinesPfizerSafetySide effectsVaccines

Donate

We depend on your donations to keep this site going. Please give what you can.

Donate Today

Comment on this Article

You’ll need to set up an account to comment if you don’t already have one. We ask for a minimum donation of £5 if you'd like to make a comment or post in our Forums.

Sign Up
Previous Post

News Round-Up

Next Post

Western Hawks Ignore Risk of Nuclear War

Subscribe
Login
Notify of
Please log in to comment

Profanity and abuse will be removed and may lead to a permanent ban.

116 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

NEWSLETTER

View today’s newsletter

To receive our latest news in the form of a daily email, enter your details here:

 

DONATE

PODCAST

Nick Dixon and Toby Young Talk About Toby’s Appearance on the 77th Brigade’s Watch List, the Scrubbing of the Internet After the Pfizer Sting and the Trans Insanity Unfolding in Scotland

by Will Jones
31 January 2023
0

LISTED ARTICLES

  • Most Read
  • Most Commented
  • Editors Picks

News Round-Up

4 February 2023
by Will Jones

94% of Claims to the Government’s Vaccine Injury Payment Scheme Are Rejected, Many Because They Are Not “60% Disabled”. Mark Kerry is One of Them

3 February 2023
by Claire Hibbs

Vitamin D Cuts COVID-19 Risk of Death in Half, New Study Finds. So Why Isn’t it Recommended?

3 February 2023
by Will Jones

The Fightback Against the Woke Capture of Scottish Schools Begins

4 February 2023
by Stuart Waiton

The Inside Story of How UsForThem Held Pfizer to Account for Misleading Parents about Covid Vaccine Safety

3 February 2023
by Ben Kingsley and Molly Kingsley

94% of Claims to the Government’s Vaccine Injury Payment Scheme Are Rejected, Many Because They Are Not “60% Disabled”. Mark Kerry is One of Them

54

News Round-Up

52

Vitamin D Cuts COVID-19 Risk of Death in Half, New Study Finds. So Why Isn’t it Recommended?

53

Delilah Is the Latest Victim of the Woke Brigade

26

News Round-Up

65

The Ministry of Climate Truth

3 February 2023
by Chris Morrison

The Alarming Trend in Core Mortality Since the Vaccine Rollout

3 February 2023
by Nick Bowler

99 Doctors and Medical Professionals Demand the British Heart Foundation Comes Clean About Vaccine Heart Injury ‘Cover-Up’

2 February 2023
by Will Jones

Masks Don’t Work, Gold Standard Review of Trial Data Concludes

2 February 2023
by Dr Robert Malone

Democratic Countries Must Reject This WHO Power Grab That Threatens Global Lockdowns and Vaccine Mandates

2 February 2023
by Dr David Bell

POSTS BY DATE

May 2022
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Apr   Jun »

SOCIAL LINKS

Free Speech Union
  • Home
  • About us
  • Donate
  • Privacy Policy

Facebook

Twitter

Instagram

RSS

Subscribe to our newsletter

© Skeptics Ltd.

No Result
View All Result
  • Articles
  • About
  • Archive
    • ARCHIVE
    • NEWS ROUND-UPS
  • Forum
  • Donate
  • Newsletter

© Skeptics Ltd.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Please note: To be able to comment on our articles you'll need to be a registered donor

Already have an account?
Please click here to login Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
wpDiscuz
You are going to send email to

Move Comment